Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Proactive esophageal cooling during radiofrequency cardiac ablation: data update including applications in very high-power short duration ablation

  • Sharkoski, Tiffany
  • Zagrodzky, Jason
  • Warrier, Nikhil
  • Doshi, Rahul
  • Omotoye, Samuel
  • Mercado Montoya, Marcela
  • Gomez Bustamante, Tatiana
  • Kulstad, Erik
  • Metzl, Mark
  • Berjano, Enrique|||0000-0002-3247-2665
  • González-Suárez, Ana|||0000-0002-1813-4176
[EN] Introduction Proactive esophageal cooling reduces injury during radiofrequency (RF) ablation of the left atrium (LA) for the treatment of atrial fibrillation (AF). New catheters are capable of higher wattage settings up to 90 W (very high-power short duration, vHPSD) for 4 s. Varying power and duration, however, does not eliminate the risk of thermal injury. Furthermore, alternative energy sources such as pulsed field ablation (PFA) also exhibit thermal effects, with clinical data showing esophageal temperatures up to 40.3°C. The ensoETM esophageal cooling device (Attune Medical, now a part of Haemonetics, Boston, MA, U.S.A.) is commercially available and FDA-cleared to reduce thermal injury to the esophagus during RF ablation for AF and is recommended in the 2024 expert consensus statement on catheter and surgical ablation of AF. Areas covered This review summarizes growing evidence of esophageal cooling during high power RF ablation for AF treatment, including data relating to procedural efficacy, safety, and efficiency, and techniques to enhance operator success while providing directions for further research. Expert opinion Proactive esophageal cooling reduces injury to the esophagus during high power RF ablation, and utilizing this approach may result in increased success in first-pass isolation, procedural efficiency, and long-term efficacy. Plain Language Summary Atrial fibrillation is a condition that causes the heart to beat irregularly, which then may cause symptoms such as palpitations, shortness of breath, dizziness, and chest pain. Atrial fibrillation increases a person¿s risk of heart failure, dementia, stroke, and death. Radiofrequency catheter ablation is a frequently employed treatment option for atrial fibrillation. This is an elective procedure performed by specialty physicians called electrophysiologists. This treatment uses a thermal (heat) energy source to create scars in the heart that block the irregular or chaotic heartbeats. There are multiple approaches to delivering this energy, including delivering moderate energy over a specified time frame as well as delivering very high amounts of energy over a much-shortened time frame. Despite the approach used, one complication of this type of energy delivery is unintended injury to the esophagus, the organ behind the heart that passes food from the mouth to the stomach. In severe cases, this injury can develop into an atrioesophageal fistula, an abnormal connection between the heart and the esophagus, which can result in death. In this review, we discuss an available device that helps prevent this type of injury in both standard and higher energy delivery, without compromising the efficacy or efficiency of the procedure., Some research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number R44HL158375 (the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health), and the Spanish Ministerio de Ciencia e Innovacion, Agencia Estatal de Investigacion, Fondo Europeo de Desarrollo Regional [Grants PID2022-136273OA-C33 and PID2022-136273OB-C31 funded by MICIU/AEI/10.13039/501100011033/ERDF, UE, and the RYC2022-036965-I funded by MICIU/AEI/10.13039/501100011033 and ESF+].
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Mechanisms of Action Behind the Protective Effects of Proactive Esophageal Cooling During Radiofrequency Catheter Ablation in the Left Atrium

  • Omotoye, Samuel
  • Singleton, Matthew
  • Zagrodzky, Jason
  • Clark, Bradley
  • Sharma, Dinesh
  • Metzl, Mark
  • Gallagher, Mark M
  • Meininghaus, Dirk Grosse
  • Leung, Lisa
  • Garg, Jalaj
  • Warrier, Nikhil
  • Panico, Ambrose
  • Tamirisa, Kamala
  • Berjano, Enrique|||0000-0002-3247-2665
  • González-Suárez, Ana|||0000-0002-1813-4176
[EN] Proactive esophageal cooling for the purpose of reducing the likelihood ofablation-relatedesophagealinjury resulting from radiofrequency (RF) cardiac ablation procedures is increasingly being used and has been Food and Drug Administration cleared as a protective strategy during left atrial RF ablation for the treatment of atrial fibrillation. In this review, we examine the evidence supporting the use of proactive esophageal cooling and the potential mechanisms of action that reduce the likelihood of atrioesophageal fistula (AEF) formation. Although the pathophysiology behindAEF formationafter thermalinjury fromRFablation is not well studied, a robust literature on fistula formation in other conditions (eg, Crohn disease, cancer, and trauma) exists and the relationship to AEF formation is investigated in this review. Likewise, we examine theabundant datain the surgicalliterature on burnand thermal injury progression as well as the acute and chronic mitigating effects of cooling.We discuss the relationship of these data andmaladaptive healingmechanisms to thewell-recognizedpostablation pathophysiological effects after RF ablation. Finally, we review additionalimportant considerations such as patient selection, clinical workflow, and implementation strategies for proactive esophageal cooling., Some authors are supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (under award number R44HL158375) for the evaluation of esophageal cooling.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Proactive esophageal cooling protects against thermal insults during high-power short-duration radiofrequency cardiac ablation

  • Mercado Montoya, Marcela
  • Gomez Bustamante, Tatiana
  • Mickelsen, Steven R.
  • Daniels, James D.
  • Hernández Arango, Pablo
  • Schieber, Jay
  • Kulstad, Erik
  • Berjano, Enrique|||0000-0002-3247-2665
[EN] Background Proactive cooling with a novel cooling device has been shown to reduce endoscopically identified thermal injury during radiofrequency (RF) ablation for the treatment of atrial fibrillation using medium power settings. We aimed to evaluate the effects of proactive cooling during high-power short-duration (HPSD) ablation. Methods A computer model accounting for the left atrium (1.5 mm thickness) and esophagus including the active cooling device was created. We used the Arrhenius equation to estimate the esophageal thermal damage during 50 W/ 10 s and 90 W/ 4 s RF ablations. Results With proactive esophageal cooling in place, temperatures in the esophageal tissue were significantly reduced from control conditions without cooling, and the resulting percentage of damage to the esophageal wall was reduced around 50%, restricting damage to the epi-esophageal region and consequently sparing the remainder of the esophageal tissue, including the mucosal surface. Lesions in the atrial wall remained transmural despite cooling, and maximum width barely changed (<0.8 mm). Conclusions Proactive esophageal cooling significantly reduces temperatures and the resulting fraction of damage in the esophagus during HPSD ablation. These findings offer a mechanistic rationale explaining the high degree of safety encountered to date using proactive esophageal cooling, and further underscore the fact that temperature monitoring is inadequate to avoid thermal damage to the esophagus., Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R44HL158375 (the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health) and by the Spanish Ministerio de Ciencia, Innovacion y Universidades/Agencia Estatal de Investigacion (MCIN/AEI/10.13039/501100011033 under grant RTI2018-094357-B-C21).